APA (7th ed.) Citation

C, R., J, N., A, R., JP, S., B, D. P., X, B., . . . JV, L. (2026). Efficacy of Low-Dose Naltrexone in Women With Fibromyalgia Syndrome: A 12-Month Randomised, Double-Blind, Placebo-Controlled Single-Centre Clinical Trial (INNOVA Study). European journal of pain (London, England), 30(6), e70321. https://doi.org/10.1002/ejp.70321

Chicago Style (17th ed.) Citation

C, Rodríguez-Freire, Navarrete J, Rozadilla-Sacanell A, Sanabria-Mazo JP, Del Pino-Gaya B, Borràs X, Feliu-Soler A, and Luciano JV. "Efficacy of Low-Dose Naltrexone in Women With Fibromyalgia Syndrome: A 12-Month Randomised, Double-Blind, Placebo-Controlled Single-Centre Clinical Trial (INNOVA Study)." European Journal of Pain (London, England) 30, no. 6 (2026): e70321. https://doi.org/10.1002/ejp.70321.

MLA (9th ed.) Citation

C, Rodríguez-Freire, et al. "Efficacy of Low-Dose Naltrexone in Women With Fibromyalgia Syndrome: A 12-Month Randomised, Double-Blind, Placebo-Controlled Single-Centre Clinical Trial (INNOVA Study)." European Journal of Pain (London, England), vol. 30, no. 6, 2026, p. e70321, https://doi.org/10.1002/ejp.70321.